Newsletters
ePaper
My Account
Home
Elections
India
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
IPL
News Shots
Explainers
Bengaluru
Science
Trending
Brandspot
Photos
Newsletters
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
Covaxin
Covaxin developed with single-minded focus on safety first: Bharat Biotech
The vaccine was evaluated in more than 27,000 subjects as part of its licensure process, Bharat Biotech stated.
02 May 2024, 17:04 IST
Covaxin developed with single-minded focus on safety first: Bharat Biotech
02 May 2024, 17:04 IST
No link between Covid vaccines used in India and heart attack risk, reveals study
The research, published recently in the journal 'PLOS One', determined the impact of Covid-19 vaccination on mortality following acute myocardial infarction (AMI) or heart attack.
04 September 2023, 12:14 IST
No link between Covid vaccines used in India and heart attack risk, reveals study
04 September 2023, 12:14 IST
IIT making Covid jab with low risk of blood clotting
They said the 'next-generation' vaccine is currently in the animal trials phase
16 February 2023, 16:28 IST
IIT making Covid jab with low risk of blood clotting
16 February 2023, 16:28 IST
Covaxin approval not due to political pressure: Govt
The ministry said CDSCO followed a scientific approach and prescribed norms in approving Covid vaccines for emergency use authorisation
17 November 2022, 15:17 IST
Covaxin approval not due to political pressure: Govt
17 November 2022, 15:17 IST
Japan approves Covaxin booster dose for travellers
In April this year, the Japanese government had announced including Covaxin in its list of recognised vaccines
05 August 2022, 17:12 IST
Japan approves Covaxin booster dose for travellers
05 August 2022, 17:12 IST
Covaxin booster works against emerging variants: Study
The study was conducted in 184 subjects, who received either a Covaxin booster dose or a placebo, six months after the primary series of two doses
20 July 2022, 14:42 IST
Covaxin booster works against emerging variants: Study
20 July 2022, 14:42 IST
NTAGI may consider Corbevax as heterologous booster vax
DCGI on June 4 approved Corbevax as a precaution dose for those aged 18 and above
27 June 2022, 15:53 IST
NTAGI may consider Corbevax as heterologous booster vax
27 June 2022, 15:53 IST
DH NewsRush | June 17 | Agnipath | COVAXIN for kids | Genome sequencing | ACB raids | FIFA 2026
17 June 2022, 16:47 IST
DH NewsRush | June 17 | Agnipath | COVAXIN for kids | Genome sequencing | ACB raids | FIFA 2026
17 June 2022, 16:47 IST
Covaxin safe, immunogenic in those aged 2-18: Study
The clinical trial conducted in the paediatric population between June 2021 to September 2021 has shown safety, less reactogenic, and robust immunogenicity
17 June 2022, 10:17 IST
Covaxin safe, immunogenic in those aged 2-18: Study
17 June 2022, 10:17 IST
'Covaxin 3rd dose boosts jab efficacy against variants'
The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were observed
15 June 2022, 07:44 IST
'Covaxin 3rd dose boosts jab efficacy against variants'
15 June 2022, 07:44 IST
<
1
2
...
68
>